Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0SB8X
|
|||
| Former ID |
DIB006389
|
|||
| Drug Name |
FluNhance
|
|||
| Synonyms |
Influenza vaccine (rNA), Protein Sciences Corp; Influenza vaccine (recombinant neuraminidase), Protein Sciences Corp; RNeuraminidase based vaccine (influenza virus infection), Protein Sciences Corp
Click to Show/Hide
|
|||
| Indication | Adenosine deaminase defciency [ICD-11: 4A01.1] | Phase 3 | [1] | |
| Influenza virus infection [ICD-11: 1E30-1E32] | Phase 2 | [2] | ||
| Company |
Protein sciences
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800010156) | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.